AACR Journals
@aacrjournals.bsky.social
The American Association for Cancer Research’s 10 peer-reviewed journals provide a renowned, respected forum for publishing the most innovative cancer science, encompassing the full spectrum of basic, translational, clinical, and epidemiological research.
Read this recent In Focus article in Blood Cancer Discovery, The Global State of Blood Cancers: An Ongoing Challenge by @lilliansiu.bsky.social buff.ly/lzyYvgE
November 18, 2025 at 10:10 PM
Read this recent In Focus article in Blood Cancer Discovery, The Global State of Blood Cancers: An Ongoing Challenge by @lilliansiu.bsky.social buff.ly/lzyYvgE
Read this collection of impactful Blood Cancer Discovery articles that highlight advanced lymphoma research by leveraging novel tools and techniques, uncovering molecular networks that drive oncogenesis and progression, and bringing innovative therapies to patients. buff.ly/q3NmZc2
November 18, 2025 at 10:05 PM
Read this collection of impactful Blood Cancer Discovery articles that highlight advanced lymphoma research by leveraging novel tools and techniques, uncovering molecular networks that drive oncogenesis and progression, and bringing innovative therapies to patients. buff.ly/q3NmZc2
In the November 1 issue of Clinical Cancer Research, Immune MRD in MM patients on lenalidomide maintenance.
Immune MRD Status Informs Tumor MRD Outcome Prognostication in Patients with Multiple Myeloma on Lenalidomide Maintenance
AbstractPurpose:. Lenalidomide (Len) maintenance is the most frequently utilized approach for newly diagnosed patients with multiple myeloma following induction therapy with/without consolidative…
buff.ly
November 18, 2025 at 5:02 PM
In the November 1 issue of Clinical Cancer Research, Immune MRD in MM patients on lenalidomide maintenance.
Read article collections featuring impactful, cutting-edge research on Tumor Metabolism, Cancer Health Disparities, and more: buff.ly/Oi8by86
November 17, 2025 at 4:18 PM
Read article collections featuring impactful, cutting-edge research on Tumor Metabolism, Cancer Health Disparities, and more: buff.ly/Oi8by86
The Cancer Discovery Early Career Award recognizes outstanding early career investigators who have authored peer-reviewed, original articles published in the journal that have made a significant impact in one or more of the fields represented by the journal.
Nominations are open! buff.ly/jUwZsdd
Nominations are open! buff.ly/jUwZsdd
November 17, 2025 at 2:33 PM
The Cancer Discovery Early Career Award recognizes outstanding early career investigators who have authored peer-reviewed, original articles published in the journal that have made a significant impact in one or more of the fields represented by the journal.
Nominations are open! buff.ly/jUwZsdd
Nominations are open! buff.ly/jUwZsdd
New article type from Cancer Epidemiology, Biomarkers & Prevention: The Resource Report covers major population-focused data resources, including cohorts, consortia, networks, registries, and other valuable datasets.
➡️Read the collection: buff.ly/MFoGugc
➡️Submit a Resource Report: buff.ly/FEFJy8y
➡️Read the collection: buff.ly/MFoGugc
➡️Submit a Resource Report: buff.ly/FEFJy8y
November 16, 2025 at 5:02 PM
New article type from Cancer Epidemiology, Biomarkers & Prevention: The Resource Report covers major population-focused data resources, including cohorts, consortia, networks, registries, and other valuable datasets.
➡️Read the collection: buff.ly/MFoGugc
➡️Submit a Resource Report: buff.ly/FEFJy8y
➡️Read the collection: buff.ly/MFoGugc
➡️Submit a Resource Report: buff.ly/FEFJy8y
This Cancer Immunology Research article shows that biparatopic CARs targeting dual epitopes of TROP2 overcome the resistance seen to current TROP2-targeted ADCs, highlighting the potential of rational structure-based CAR engineering to overcome resistance to antibody-based therapies in solid tumors.
Systematic Engineering of TROP2-Targeted CAR T-Cell Therapy Overcomes Resistance Pathways in Solid Tumors
The authors show that biparatopic CARs targeting dual epitopes of TROP2 overcome the resistance seen to current TROP2-targeted ADCs, highlighting the potential of rational structure-based CAR…
doi.org
November 15, 2025 at 5:02 PM
This Cancer Immunology Research article shows that biparatopic CARs targeting dual epitopes of TROP2 overcome the resistance seen to current TROP2-targeted ADCs, highlighting the potential of rational structure-based CAR engineering to overcome resistance to antibody-based therapies in solid tumors.
Did you know - AACR Journals offers simultaneous publication opportunities. Contact Karen Honey, Executive Editor of Cancer Immunology Research, about submitting your related manuscript: karen.honey@aacr.org
Submit an abstract by December 1 for the AACR IO Conference on Discovery and Innovation in Cancer Immunology (February 18-21, 2026; Los Angeles), chaired by Nina Bhardwaj and Antoni Ribas. Learn more:
buff.ly/TUarANa
#AACRIO26
buff.ly/TUarANa
#AACRIO26
November 14, 2025 at 8:34 PM
Did you know - AACR Journals offers simultaneous publication opportunities. Contact Karen Honey, Executive Editor of Cancer Immunology Research, about submitting your related manuscript: karen.honey@aacr.org
Learn how AACR’s #openaccess, peer-reviewed journal—Cancer Research Communications—supports authors from presubmission through publication: buff.ly/NTCCGgR
November 14, 2025 at 5:59 PM
Learn how AACR’s #openaccess, peer-reviewed journal—Cancer Research Communications—supports authors from presubmission through publication: buff.ly/NTCCGgR
📣 New collection alert!
Advances in Targeted Protein Degradation: PROTACs and Molecular Glues buff.ly/xdWDulw
This collection features recent research and review articles highlighting key advances in PROTAC and molecular glue development.
Advances in Targeted Protein Degradation: PROTACs and Molecular Glues buff.ly/xdWDulw
This collection features recent research and review articles highlighting key advances in PROTAC and molecular glue development.
November 12, 2025 at 5:05 PM
📣 New collection alert!
Advances in Targeted Protein Degradation: PROTACs and Molecular Glues buff.ly/xdWDulw
This collection features recent research and review articles highlighting key advances in PROTAC and molecular glue development.
Advances in Targeted Protein Degradation: PROTACs and Molecular Glues buff.ly/xdWDulw
This collection features recent research and review articles highlighting key advances in PROTAC and molecular glue development.
New in Blood Cancer Discovery: Cancer Cell–Intrinsic CAR T Resistance in #DLBCL
Acquisition of DLBCL-intrinsic CD19 CAR-T cell therapy resistance in cell lines identifies a cross-antigen resistant phenotype with a gene signature predictive of clinical CAR-T response. Read more:
Acquisition of DLBCL-intrinsic CD19 CAR-T cell therapy resistance in cell lines identifies a cross-antigen resistant phenotype with a gene signature predictive of clinical CAR-T response. Read more:
DLBCL Cells Emerge after CD19 CAR T Cells with Cross-Antigen Resistance and a Gene Signature Predictive of Clinical CAR T-cell Response
Acquisition of DLBCL-intrinsic CD19 CAR-T cell therapy resistance in cell lines identifies a cross-antigen resistant phenotype with a gene signature predictive of clinical CAR-T response.
buff.ly
November 11, 2025 at 5:04 PM
New in Blood Cancer Discovery: Cancer Cell–Intrinsic CAR T Resistance in #DLBCL
Acquisition of DLBCL-intrinsic CD19 CAR-T cell therapy resistance in cell lines identifies a cross-antigen resistant phenotype with a gene signature predictive of clinical CAR-T response. Read more:
Acquisition of DLBCL-intrinsic CD19 CAR-T cell therapy resistance in cell lines identifies a cross-antigen resistant phenotype with a gene signature predictive of clinical CAR-T response. Read more:
From the November issue of Cancer Immunology Research, check out Tunneling CARs: Increasing CAR T-Cell Tumor Infiltration through the Overexpression of MMP-7 and Osteopontin-b
Tunneling CARs: Increasing CAR T-Cell Tumor Infiltration through the Overexpression of MMP-7 and Osteopontin-b
Inadequate CAR T-cell infiltration into solid tumors limits efficacy. The authors show that engineering CAR T cells to express osteopontin can overcome physical barriers in solid tumors, offering a…
doi.org
November 11, 2025 at 2:16 PM
From the November issue of Cancer Immunology Research, check out Tunneling CARs: Increasing CAR T-Cell Tumor Infiltration through the Overexpression of MMP-7 and Osteopontin-b
Robert Kruger, PhD, Senior Executive Editor of Cancer Discovery, joined Zhongshan Hospital Assistant President Qiang Gao, PhD, to chair the opening session of the 2025 CACA Cancer Discovery Symposium at CCHIO 2025. We thank all of the speakers for their contributions to an outstanding program.
November 10, 2025 at 4:11 PM
Robert Kruger, PhD, Senior Executive Editor of Cancer Discovery, joined Zhongshan Hospital Assistant President Qiang Gao, PhD, to chair the opening session of the 2025 CACA Cancer Discovery Symposium at CCHIO 2025. We thank all of the speakers for their contributions to an outstanding program.
Sign up to receive alerts directly to your inbox to keep up with the latest published issues: buff.ly/O6OYSDp
November 10, 2025 at 4:08 PM
Sign up to receive alerts directly to your inbox to keep up with the latest published issues: buff.ly/O6OYSDp
#ICYMI: Nominations for the 2026 Early Career Awards are open. The Award recipients will be invited to the Journals Reception that takes place during the AACR Annual Meeting and awarded $1,500. Find out more: buff.ly/Vhxuyt5
November 8, 2025 at 5:02 PM
#ICYMI: Nominations for the 2026 Early Career Awards are open. The Award recipients will be invited to the Journals Reception that takes place during the AACR Annual Meeting and awarded $1,500. Find out more: buff.ly/Vhxuyt5
"The journal selection process was straightforward, aligning well with our research focus." -Minah Kim, Cancer Research Author
See more of what our authors are saying about publishing with the Journals. buff.ly/7x8ra8e
See more of what our authors are saying about publishing with the Journals. buff.ly/7x8ra8e
November 6, 2025 at 5:07 PM
"The journal selection process was straightforward, aligning well with our research focus." -Minah Kim, Cancer Research Author
See more of what our authors are saying about publishing with the Journals. buff.ly/7x8ra8e
See more of what our authors are saying about publishing with the Journals. buff.ly/7x8ra8e
The Immuno-oncology collection highlights recent advances in immuno-oncology, including identification of biomarkers of response to immunotherapies, neoantigen vaccine development, antibody therapies, and cellular therapies. Check it out: buff.ly/L4GpWAx
November 5, 2025 at 11:14 PM
The Immuno-oncology collection highlights recent advances in immuno-oncology, including identification of biomarkers of response to immunotherapies, neoantigen vaccine development, antibody therapies, and cellular therapies. Check it out: buff.ly/L4GpWAx
Read the related article in Clinical Cancer Research, "SJPedPanel: A Pan-Cancer Gene Panel for Childhood Malignancies to Enhance Cancer Monitoring and Early Detection." doi.org/10.1158/1078...
Learn how researchers are tackling the challenge of identifying which children are at risk and determining the most effective interventions to support their long-term health in the 2025 Scientific Report. ow.ly/L3BW50XlRNk
ow.ly
November 4, 2025 at 2:51 PM
Read the related article in Clinical Cancer Research, "SJPedPanel: A Pan-Cancer Gene Panel for Childhood Malignancies to Enhance Cancer Monitoring and Early Detection." doi.org/10.1158/1078...
Nominations for the 2026 Early Career Awards are open for Cancer Discovery, Cancer Research, and Clinical Cancer Research!
View criteria and be the first to submit a nomination: buff.ly/Vhxuyt5
View criteria and be the first to submit a nomination: buff.ly/Vhxuyt5
November 3, 2025 at 5:06 PM
Nominations for the 2026 Early Career Awards are open for Cancer Discovery, Cancer Research, and Clinical Cancer Research!
View criteria and be the first to submit a nomination: buff.ly/Vhxuyt5
View criteria and be the first to submit a nomination: buff.ly/Vhxuyt5
Read the new article just published in Blood Cancer Discovery: Tandem duplications in UBTF create XPO1-dependent nuclear export signals that reveal a leukemic therapeutic dependency
doi.org/10.1158/2643...
doi.org/10.1158/2643...
November 3, 2025 at 3:27 PM
Read the new article just published in Blood Cancer Discovery: Tandem duplications in UBTF create XPO1-dependent nuclear export signals that reveal a leukemic therapeutic dependency
doi.org/10.1158/2643...
doi.org/10.1158/2643...
When you submit to an AACR Journal, you'll benefit from rapid decision and publication times. Learn more about the Manuscript Turnaround Guarantee for Active AACR Members: buff.ly/KP7I5Z6
October 29, 2025 at 7:42 PM
When you submit to an AACR Journal, you'll benefit from rapid decision and publication times. Learn more about the Manuscript Turnaround Guarantee for Active AACR Members: buff.ly/KP7I5Z6
📅 Next week!
Nominations will open for the 2025 Cancer Research Early Career Award.
Stay tuned!
Nominations will open for the 2025 Cancer Research Early Career Award.
Stay tuned!
October 29, 2025 at 4:06 PM
📅 Next week!
Nominations will open for the 2025 Cancer Research Early Career Award.
Stay tuned!
Nominations will open for the 2025 Cancer Research Early Career Award.
Stay tuned!
Not only do AACR Members receive a 10% discount on publishing fees, but some AACR scientific working groups offer additional discounts on top of this. Learn more: buff.ly/12PgSmX
October 28, 2025 at 7:51 PM
Not only do AACR Members receive a 10% discount on publishing fees, but some AACR scientific working groups offer additional discounts on top of this. Learn more: buff.ly/12PgSmX
Cancer Discovery News: Highlighting Must-Read Industry News. buff.ly/hNe0xKN
October 27, 2025 at 4:07 PM
Cancer Discovery News: Highlighting Must-Read Industry News. buff.ly/hNe0xKN